NVS Projected Dividend Yield
ADR (Sponsored)/Novartis AG Basel ( NYSE : NVS )Novartis is a holding company. Through its subsidiaries, Co. is a multinational group of companies focusing on the research, development, manufacturing and marketing of a range of pharmaceuticals and generic medicines. Co. comprises two divisions: Innovative Medicines, which researches, develops, manufactures, distributes and sells patented pharmaceuticals; and Sandoz, which develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients, and has three franchises, Retail Generics, Anti-Infectives and Biopharmaceuticals. 20 YEAR PERFORMANCE RESULTS |
NVS Dividend History Detail NVS Dividend News NVS Competitors News |
Year | Declaration Date | Ex-Dividend Date | Record Date | Payable Date | Dividend $ Amount |
2023 | N/A | Mar 09, 2023 | Mar 10, 2023 | Mar 20, 2023 | 2.2742 |
2023 Total: | 2.2742 | ||||
2022 | N/A | Mar 08, 2022 | Mar 09, 2022 | Mar 17, 2022 | 2.1614 |
2022 Total: | 2.1614 | ||||
2021 | N/A | Mar 04, 2021 | Mar 05, 2021 | Mar 15, 2021 | 2.0794 |
2021 Total: | 2.0794 | ||||
2020 | N/A | Mar 03, 2020 | Mar 04, 2020 | Mar 12, 2020 | 2.0068 |
2020 Total: | 2.0068 | ||||
2019 | N/A | Mar 04, 2019 | Mar 05, 2019 | Mar 13, 2019 | 1.8422 |
2019 Total: | 1.8422 |